Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Srikripa Devarakonda is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | INCY | Buy Now | Incyte | $60.00 | 20% | Srikripa Devarakonda50% | $74 → $72 | Maintains | Hold | Get Alert |
| 03/11/2025 | PTGX | Buy Now | Protagonist Therapeutics | $54.25 | 40.09% | Srikripa Devarakonda50% | $60 → $76 | Maintains | Buy | Get Alert |
| 02/13/2025 | BIIB | Buy Now | Biogen | $143.09 | 46.76% | Srikripa Devarakonda50% | $220 → $210 | Maintains | Buy | Get Alert |
| 02/03/2025 | LLY | Buy Now | Eli Lilly | $821.00 | 26.43% | Srikripa Devarakonda50% | $1029 → $1038 | Maintains | Buy | Get Alert |
| 02/03/2025 | ABBV | Buy Now | AbbVie | $214.59 | 1.12% | Srikripa Devarakonda50% | $211 → $217 | Maintains | Buy | Get Alert |
| 01/08/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 50.99% | Srikripa Devarakonda50% | $1126 → $1004 | Maintains | Buy | Get Alert |
| 01/08/2025 | BIIB | Buy Now | Biogen | $143.09 | 53.75% | Srikripa Devarakonda50% | $302 → $220 | Maintains | Buy | Get Alert |
| 01/08/2025 | ABBV | Buy Now | AbbVie | $214.59 | -1.68% | Srikripa Devarakonda50% | $215 → $211 | Maintains | Buy | Get Alert |
| 12/23/2024 | KROS | Buy Now | Keros Therapeutics | $11.40 | 277.19% | Srikripa Devarakonda50% | $100 → $43 | Maintains | Buy | Get Alert |
| 12/18/2024 | PFE | Buy Now | Pfizer | $26.30 | 21.67% | Srikripa Devarakonda50% | $36 → $32 | Maintains | Buy | Get Alert |
| 11/27/2024 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | 88.47% | Srikripa Devarakonda50% | $33 → $50 | Maintains | Buy | Get Alert |
| 11/25/2024 | SRRK | Buy Now | Scholar Rock Holding | $33.88 | 32.82% | Srikripa Devarakonda50% | $36 → $45 | Maintains | Buy | Get Alert |
| 11/01/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 69.33% | Srikripa Devarakonda50% | $1137 → $1126 | Maintains | Buy | Get Alert |
| 11/01/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 55.74% | Srikripa Devarakonda50% | $54 → $53 | Reiterates | Buy → Buy | Get Alert |
| 10/16/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 70.99% | Srikripa Devarakonda50% | $1200 → $1137 | Maintains | Buy | Get Alert |
| 10/10/2024 | LLY | Buy Now | Eli Lilly | $821.00 | 25.82% | Srikripa Devarakonda50% | $1000 → $1033 | Maintains | Buy | Get Alert |
| 10/10/2024 | ABBV | Buy Now | AbbVie | $214.59 | 0.19% | Srikripa Devarakonda50% | $210 → $215 | Maintains | Buy | Get Alert |
| 09/27/2024 | BMEA | Buy Now | Biomea Fusion | $2.53 | 2034.39% | Srikripa Devarakonda50% | $54 → $54 | Upgrade | Hold → Buy | Get Alert |
| 09/24/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 80.46% | Srikripa Devarakonda50% | $1200 → $1200 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2024 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | 24.39% | Srikripa Devarakonda50% | $25 → $33 | Maintains | Buy | Get Alert |
| 09/18/2024 | INCY | Buy Now | Incyte | $60.00 | 23.33% | Srikripa Devarakonda50% | $83 → $74 | Downgrade | Buy → Hold | Get Alert |
| 09/09/2024 | PTGX | Buy Now | Protagonist Therapeutics | $54.25 | 10.6% | Srikripa Devarakonda50% | → $60 | Initiates | → Buy | Get Alert |
| 08/13/2024 | VSTM | Buy Now | Verastem | $6.50 | 130.77% | Srikripa Devarakonda50% | $18 → $15 | Maintains | Buy | Get Alert |
| 08/05/2024 | BIIB | Buy Now | Biogen | $143.09 | 111.06% | Srikripa Devarakonda50% | $340 → $302 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 80.46% | Srikripa Devarakonda50% | $1135 → $1200 | Reiterates | Buy → Buy | Get Alert |
| 07/31/2024 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 163.54% | Srikripa Devarakonda50% | → $36 | Initiates | → Buy | Get Alert |
| 07/08/2024 | VSTM | Buy Now | Verastem | $6.50 | 176.92% | Srikripa Devarakonda50% | $34 → $18 | Maintains | Buy | Get Alert |
| 06/25/2024 | LLY | Buy Now | Eli Lilly and Co | $821.00 | 21.8% | Srikripa Devarakonda50% | $892 → $1000 | Reiterates | Buy → Buy | Get Alert |
| 06/18/2024 | KROS | Buy Now | Keros Therapeutics | $11.40 | 777.19% | Srikripa Devarakonda50% | $100 → $100 | Maintains | Buy | Get Alert |
| 05/29/2024 | CYTK | Buy Now | Cytokinetics | $43.48 | 60.99% | Srikripa Devarakonda50% | $86 → $70 | Maintains | Buy | Get Alert |
| 05/01/2024 | INCY | Buy Now | Incyte | $60.00 | 38.33% | Srikripa Devarakonda50% | $84 → $83 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | LLY | Buy Now | Eli Lilly and Co | $821.00 | 8.65% | Srikripa Devarakonda50% | $850 → $892 | Maintains | Buy | Get Alert |
| 04/17/2024 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | -5.77% | Srikripa Devarakonda50% | $25 → $25 | Maintains | Buy | Get Alert |
| 04/08/2024 | CYTK | Buy Now | Cytokinetics | $43.48 | 97.79% | Srikripa Devarakonda50% | $86 → $86 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | SRRK | Buy Now | Scholar Rock Holding | $33.88 | -40.97% | Srikripa Devarakonda50% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2024 | SRRK | Buy Now | Scholar Rock Holding | $33.88 | -40.97% | Srikripa Devarakonda50% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | KROS | Buy Now | Keros Therapeutics | $11.40 | 777.19% | Srikripa Devarakonda50% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 03/01/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 58.68% | Srikripa Devarakonda50% | $41 → $54 | Maintains | Buy | Get Alert |
| 02/14/2024 | INCY | Buy Now | Incyte | $60.00 | 40% | Srikripa Devarakonda50% | $91 → $84 | Maintains | Buy | Get Alert |
| 12/28/2023 | CYTK | Buy Now | Cytokinetics | $43.48 | 97.79% | Srikripa Devarakonda50% | $60 → $86 | Maintains | Buy | Get Alert |
| 11/29/2023 | INCY | Buy Now | Incyte | $60.00 | 51.67% | Srikripa Devarakonda50% | → $91 | Reiterates | Buy → Buy | Get Alert |
| 11/15/2023 | VSTM | Buy Now | Verastem | $6.50 | 423.08% | Srikripa Devarakonda50% | $39 → $34 | Maintains | Buy | Get Alert |
| 09/21/2023 | INCY | Buy Now | Incyte | $60.00 | 51.67% | Srikripa Devarakonda50% | → $91 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | AFMD | Buy Now | Affimed | $0.92 | 552.17% | Srikripa Devarakonda50% | $80 → $60 | Maintains | Buy | Get Alert |
| 08/02/2023 | INCY | Buy Now | Incyte | $60.00 | 51.67% | Srikripa Devarakonda50% | $100 → $91 | Maintains | Buy | Get Alert |
| 07/11/2023 | VSTM | Buy Now | Verastem | $6.50 | 500% | Srikripa Devarakonda50% | $60 → $39 | Maintains | Buy | Get Alert |
| 06/30/2023 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 46.93% | Srikripa Devarakonda50% | → $50 | Initiates | → Buy | Get Alert |
| 06/28/2023 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | -5.77% | Srikripa Devarakonda50% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/27/2023 | VSTM | Buy Now | Verastem | $6.50 | 823.08% | Srikripa Devarakonda50% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 06/27/2023 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | -5.77% | Srikripa Devarakonda50% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/23/2023 | VSTM | Buy Now | Verastem | $6.50 | 823.08% | Srikripa Devarakonda50% | → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2023 | EWTX | Buy Now | Edgewise Therapeutics | $26.53 | -5.77% | Srikripa Devarakonda50% | → $25 | Initiates | → Buy | Get Alert |
| 03/20/2023 | NMTR | Buy Now | 9 Meters Biopharma | — | — | Srikripa Devarakonda50% | → $38 | Downgrade | Buy → Hold | Get Alert |
| 02/16/2023 | INCY | Buy Now | Incyte | $60.00 | 66.67% | Srikripa Devarakonda50% | $95 → $100 | Maintains | Buy | Get Alert |
| 12/20/2022 | CYTK | Buy Now | Cytokinetics | $43.48 | 37.99% | Srikripa Devarakonda50% | → $60 | Initiates | → Buy | Get Alert |
| 10/18/2022 | KROS | Buy Now | Keros Therapeutics | $11.40 | 777.19% | Srikripa Devarakonda50% | → $100 | Initiates | → Buy | Get Alert |
| 07/12/2022 | SRRK | Buy Now | Scholar Rock Holding | $33.88 | -40.97% | Srikripa Devarakonda50% | → $20 | Initiates | → Buy | Get Alert |
| 06/22/2022 | NMTR | Buy Now | 9 Meters Biopharma | — | — | Srikripa Devarakonda50% | $100 → $40 | Maintains | Buy | Get Alert |
| 03/09/2022 | VSTM | Buy Now | Verastem | $6.50 | -7.69% | Srikripa Devarakonda50% | → $72 | Initiates | → Buy | Get Alert |
| 10/21/2021 | AFMD | Buy Now | Affimed | $0.92 | 986.96% | Srikripa Devarakonda50% | → $100 | Initiates | → Buy | Get Alert |
| 06/03/2021 | CNST | Buy Now | Constellation | — | — | Srikripa Devarakonda50% | $50 → $34 | Downgrade | Buy → Hold | Get Alert |
| 01/07/2021 | INCY | Buy Now | Incyte | $60.00 | 100% | Srikripa Devarakonda50% | → $120 | Initiates | → Buy | Get Alert |
| 06/30/2020 | NMTR | Buy Now | 9 Meters Biopharma | — | — | Srikripa Devarakonda50% | → $100 | Initiates | → Buy | Get Alert |
| 02/13/2020 | CNST | Buy Now | Constellation | — | — | Srikripa Devarakonda50% | → $50 | Initiates | → Buy | Get Alert |
